CoChat

Antidepressants and the adolescent brain

Cousins, Lesley, Goodyer, Ian M · 2015 · Journal of Psychopharmacology

The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.

Abstract

Major unipolar depression is a significant global health problem, with the highest incident risk being during adolescence. A depressive illness during this period is associated with negative long-term consequences including suicide, additional psychiatric comorbidity, interpersonal relationship problems, poor educational performance and poor employment attainment well into adult life. Despite previous safety concerns, selective serotonin reuptake inhibitors (SSRIs) remain a key component of the treatment of moderate to severe depression episodes in adolescents. The impact of SSRIs on the developing adolescent brain, however, remains unclear. In this review we first consider what is currently known about the developing brain during adolescence and how these development processes may be affected by a depressive illness. We then review our understanding of the action of SSRIs, their effects on the brain and how these may differ between adults and adolescents. We conclude that there is currently little evidence to indicate that the human adolescent brain is at developmental risk from SSRIs. Furthermore, there is no clear-cut evidence to support the concerns of marked suicidal adverse side effects accruing in depressed adolescents being treated with SSRIs. Neither, however, is there irrefutable evidence to dismiss all such concerns. This makes SSRI prescribing a matter of medical judgement, ensuring the benefits outweigh the risks for the individual patients, as with so much in therapeutics. Overall, SSRIs show clinical benefits that we judge to outweigh the risks to neurodevelopment and are an important therapeutic choice in the treatment of moderate to severe adolescent depression.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881115573542

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 148 references

Research works printed but not linked: 6

  1. Hammand T, 2004, Review and evaluation of clinical data
  2. McKinnon MC, 2009, J Psychiatry Neurosci, 34, 41
  3. NICE, 2005, Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. NICE Clinical Guideline 28
  4. Sapolsky RM, 2000, Endocr Reviews, 21, 55
  5. Tottenham N, 2009, Front Hum Neurosci, 3, 68
  6. World Health Organization, 2011, Global Burden of Mental Disorders and the Need for a Comprehensive, Coordinated Response from Health and Social Sectors at the Country Level. Report by the Secretariat

Cited by

See all 64

Metadata

Authors
Cousins, L., & Goodyer, I. M.
Affiliations
University of Cambridge (GB)
Corresponding author
Goodyer, Ian M
Venue
Journal of Psychopharmacology
Published
2015-03-05
Volume
29
Issue
5
Pages
545-555
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2143877953
Cited by
61
References
148
Citations by year
2026: 2 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 2
FWCI
0.59
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
Keywords
antidepressants, adolescents, adolescent depression, selective serotonin reuptake inhibitors, brain development, suicide risk, adverse drug reactions, major depressive disorder
MeSH terms
Adolescent, Adolescent Behavior, Antidepressive Agents, Brain, Major Depressive Disorder, Humans, Risk Factors, Suicide, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressants and the adolescent brain. https://app.cochat.ai/papers/10.1177/0269881115573542
The paper
Cousins, L., & Goodyer, I. M. (2015). Antidepressants and the adolescent brain. Journal of Psychopharmacology. https://doi.org/10.1177/0269881115573542

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.